<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04648384</url>
  </required_header>
  <id_info>
    <org_study_id>Protein Supplementation</org_study_id>
    <nct_id>NCT04648384</nct_id>
  </id_info>
  <brief_title>Acute Whey Protein And Casein Supplementation: Effect On Protein Metabolism After Resistance Exercise</brief_title>
  <official_title>Association of Whey Protein and Casein in the Same Proportions of Human Breast Milk Promoted Similar Branched-chain Amino Acids Profile and Reduced Delayed Muscle Soreness in Physically Active Man</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proteins of human breast milk are the most important endocrine signaling system that&#xD;
      promotes neonatal growth by increasing the release of insulin, insulin-like growth factor-1&#xD;
      (IGF-1), and the leucine-mediated mammalian target of rapamycin complex 1- (mTORC1) signaling&#xD;
      of pancreatic β-cells. Remarkably, the branched-chain amino acids (BCAAs) leucine,&#xD;
      isoleucine, and valine are involved in the growth-promoting effects of milk, protein&#xD;
      biosynthesis, and metabolism because they physiologically stimulate insulin secretion The&#xD;
      present study sought to investigate the effects of the combination of whey protein and casein&#xD;
      in the ratio of 80:20 (&quot;whey protein: casein&quot; or &quot;casein: whey protein&quot;) as breast milk&#xD;
      proportion on the peak and the period of the permanence of branched-chain amino acids in the&#xD;
      blood circulation, final metabolites of protein metabolism and delayed onset muscle soreness&#xD;
      (DOMS) after a single bout of fasting or a resistance exercise session.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The present study investigated the effects of the association of WP and casein in the ratio&#xD;
      of 80:20, a similar ratio of human breast milk, on blood branched-chain amino acids (BCAAs)&#xD;
      profile by HPLC technique, markers of protein metabolism (creatinine, urea, and urine&#xD;
      nitrogen) and delayed onset muscle soreness (DOMS) after a single bout of resistance&#xD;
      exercise. A double-blind, crossover and acute study was conducted with ten men (age 29 ± 8 y;&#xD;
      BMI: 25.4 ± 2.9 Kg/m2; 77 ± 12 kg; 1.74 ± 0.09 m) that were randomly assigned to five&#xD;
      supplementation treatments: WP - whey protein; CAS - casein; WP/CAS - 80% WP/20% CAS; CAS/WP&#xD;
      - 80% CAS/ 20% WP; PLA - placebo. Participants were submitted to the following evaluations:&#xD;
      performance sessions, blood collection for each session for the BCAAs profile determination,&#xD;
      two food records, 3-days assessment of DOMS (24h, 48h, 72h) after each treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 20, 2016</start_date>
  <completion_date type="Actual">October 20, 2019</completion_date>
  <primary_completion_date type="Actual">July 20, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in plasma amino acids concentration</measure>
    <time_frame>5 weeks</time_frame>
    <description>Blood sample collected for analysis of BCAA concentration after blend protein or placebo supplementation expressed in (µmol/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in 1RM test</measure>
    <time_frame>5 weeks</time_frame>
    <description>Change of training load using RPE, time and load expressed in (a.u)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in protein metabolism</measure>
    <time_frame>5 weeks</time_frame>
    <description>Change in nitrogen excretion, and nitrogen balance after protein supplementation expressed in (g/24 hours)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes from baseline in macronutrient intake</measure>
    <time_frame>5 weeks</time_frame>
    <description>Change of macronutrient intake were calculated pre and post treatment expressed in (g/24 hours)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in delayed onset muscle soreness</measure>
    <time_frame>5 weeks</time_frame>
    <description>Change from baseline the delayed onset muscle soreness pre, post, 24 hours, 48 hours and 72 hours after treatment expressed in (a.u)</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Sports Nutrition</condition>
  <condition>Protein Supplementation</condition>
  <arm_group>
    <arm_group_label>Protein Supplementation and Resistance exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Protein supplementation composed of 20 gram of whey protein or casein in different proportions (80:20) and fasting state 10 sets of 10 reps at 85% of 1 Maximum repetition</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Supplementation</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo supplementation composed of 20 gram of Maltodextrin and fasting state 10 sets of 10 reps at 85% of 1 Maximum repetition</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Resistance Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Resistance Exercise will be performed before supplementation and is composed by 10 sets of 10 repetitions at 85% of 1 Maximum repetition in leg press exercise.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Blend Protein Supplementation</intervention_name>
    <description>Protein supplementation using 20 grams of whey protein or casein mix. Acute Resistance training, 10 sets of 10 reps at 85% of 1Maximum repetition</description>
    <arm_group_label>Protein Supplementation and Resistance exercise</arm_group_label>
    <other_name>Resistance Training</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo Supplementation</intervention_name>
    <description>Placebo supplementation using 20 grams of Maltodextrin. Acute Resistance training, 10 sets of 10 reps at 85% of 1Maximum repetition</description>
    <arm_group_label>Placebo Supplementation</arm_group_label>
    <other_name>Resistance Training</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Resistance Exercise</intervention_name>
    <description>10 sets of 10 repetitions at 85% of 1 Maximum repetition in leg press exercise</description>
    <arm_group_label>Placebo Supplementation</arm_group_label>
    <arm_group_label>Protein Supplementation and Resistance exercise</arm_group_label>
    <arm_group_label>Resistance Training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy&#xD;
&#xD;
          -  practice resistance training at least 3x a week&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smokers&#xD;
&#xD;
          -  Muscle injures&#xD;
&#xD;
          -  cardiovascular diseases&#xD;
&#xD;
          -  Diabetes mellitus&#xD;
&#xD;
          -  Lactose intolerance&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of São Paulo, School of Physical Education and Sports of Ribeirão Preto.</name>
      <address>
        <city>Ribeirão Preto</city>
        <state>São Paulo</state>
        <zip>14049-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 9, 2020</study_first_submitted>
  <study_first_submitted_qc>November 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 1, 2020</study_first_posted>
  <last_update_submitted>November 30, 2020</last_update_submitted>
  <last_update_submitted_qc>November 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Ellen Cristini de Freitas</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

